接下来对于COVID-19疫苗接种是什么?
Antoni Trilla1,2,3, Guillem Trilla4,5, Marta Aldea1,2
1Department of Medicine, University of Barcelona Faculty of Medicine and Health Sciences, Barcelona, Barcelona, Spain.
Seminars in respiratory and critical care medicine
|March 31, 2025
概括
新的COVID-19疫苗接种季节在疫苗选择和沟通方面带来了挑战. 改善健康信息和简化建议可以提高疫苗接种率,以更好地保护对进化的SARS-CoV-2变种.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- SARS-CoV-2 病毒继续演变,出现了 JN.1,KP.2 和 XEC 等变种,需要更新的疫苗接种策略.
- 尽管有更新的COVID-19疫苗可用,但增强剂量摄入量正在下降,这对维持人口免疫力构成了挑战.
研究的目的:
- 为应对与新的COVID-19疫苗接种季节相关的挑战,包括疫苗选择,高风险群体的识别和有效的公众沟通.
- 探索改善疫苗接种覆盖率的策略,并确保对不断演变的SARS-CoV-2变种提供充分的保护.
主要方法:
- 这项研究是对当前COVID-19疫苗接种挑战和策略的审查和分析.
- 它综合了有关针对SARS-CoV-2主导变种的疫苗有效性和免疫力减弱概念的信息.
主要成果:
- 有更新的COVID-19疫苗可供使用,针对主要的SARS-CoV-2变种.
- 增强剂量摄入量下降表明需要改进疫苗接种促进策略.
- 有效的沟通和简化建议对于提高疫苗接种率至关重要.
结论:
- COVID-19疫苗仍然是安全有效的,主要是减轻疾病的严重程度和减少并发症.
- 加强健康信息,专业培训和简化建议对于改善疫苗接种覆盖率至关重要.
- 面对持续和不断变化的SARS-CoV-2威胁,应对这些挑战对公共卫生至关重要.
更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.4K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.4K
相关概念视频
01:51Vaccinations
43.1K
Overview
43.1K
01:30Cancer Vaccines
297
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
297
01:23Immunological Memory
473
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
473
01:31Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
00:42Cross-reactivity
30.9K
Overview
30.9K
01:22Development of Immunocompetence
271
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
271